Cancer Gene Therapy
Lanzhou University, Department of Urology details research in cancer gene therapy
Published in Cancer Weekly, October 16th, 2007
A report, 'Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells,' is newly published data in Asian Journal of Andrology. In this recent study, researchers in Lanzhou, People's Republic of China conducted a study "To investigate the effect of inhibition of telomerase with human telomerase reverse transcriptase (hTERT) antisense on tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis in prostate cancer cells (PC3). Antisense phosphorothioate oligodeoxynucleotide (AS PS-ODN) was synthesized and purified."
"Telomerase activity was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-10-16)
More Articles from Cancer Weekly
- Bioengineering
SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite - Biomedicine
New Scientists Boost Disease-based Research at Boston Biomedical Research Institute - Biomedicine
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog - Bladder Cancer
European Bladder Cancer Therapeutics Market Participants Must Explore New Areas of Drug Development to Offset Impact of Mature Product Lines - Brain Cancer
Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement - Breast Cancer
ADVISORY/Safeway Unveils State-of-the-Art Mobile Mammography Unit at Breast Cancer Awareness Town Hall - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
